SILENCING OF CSN5 GENE EXPRESSION USING INTERFERING RNA
European Patent
9731523.8
Filed on 2009-04-15
9731523.8
Filed on 2009-04-15
SILENCING OF CSN5 GENE EXPRESSION USING INTERFERING RNA
United Kingdom
09731523.8
Filed on 2010-11-10
09731523.8
Filed on 2010-11-10
SILENCING OF CSN5 GENE EXPRESSION USING INTERFERING RNA
Germany
09731523.8
Filed on 2010-11-10
09731523.8
Filed on 2010-11-10
Therapeutic Targeting Of CSN5, A Negative Regulator Of P53 And P27, In Human Hepatocellular Carcinoma
US Application 13/551,580
Filed on 2012-07-17
Filed on 2012-07-17
Cancer Immunotherapy by Delivering Class II MHC Antigens Using A VLP-Replicon
US Application 15/104,785
Filed on 2016-06-15
Filed on 2016-06-15
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Japan
2016-558546
Filed on 2014-12-16
2016-558546
Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
European Patent
14824680.4
Filed on 2014-12-16
14824680.4
Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Canada
2934075
Filed on 2014-12-16
2934075
Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Australia
2014365777
Filed on 2014-12-16
2014365777
Filed on 2014-12-16